GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzamend Neuro Inc (FRA:9ZT1) » Definitions » PB Ratio

Alzamend Neuro (FRA:9ZT1) PB Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alzamend Neuro PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Alzamend Neuro's share price is €2.16. Alzamend Neuro's Book Value per Share for the quarter that ended in Jan. 2024 was €-0.61. Hence, Alzamend Neuro's PB Ratio of today is .

The historical rank and industry rank for Alzamend Neuro's PB Ratio or its related term are showing as below:

During the past 5 years, Alzamend Neuro's highest PB Ratio was 175.83. The lowest was 0.00. And the median was 0.00.

FRA:9ZT1's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.55
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Alzamend Neuro's average Book Value Per Share Growth Rate was -170.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 50.90% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Alzamend Neuro was 238.70% per year. The lowest was 50.90% per year. And the median was 144.80% per year.

Back to Basics: PB Ratio


Alzamend Neuro PB Ratio Historical Data

The historical data trend for Alzamend Neuro's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzamend Neuro PB Ratio Chart

Alzamend Neuro Annual Data
Trend Apr19 Apr20 Apr21 Apr22 Apr23
PB Ratio
- - - 6.60 16.88

Alzamend Neuro Quarterly Data
Apr19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.74 16.88 - - -

Competitive Comparison of Alzamend Neuro's PB Ratio

For the Biotechnology subindustry, Alzamend Neuro's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzamend Neuro's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzamend Neuro's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alzamend Neuro's PB Ratio falls into.



Alzamend Neuro PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alzamend Neuro's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jan. 2024)
=2.16/-0.605
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Alzamend Neuro  (FRA:9ZT1) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Alzamend Neuro PB Ratio Related Terms

Thank you for viewing the detailed overview of Alzamend Neuro's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzamend Neuro (FRA:9ZT1) Business Description

Traded in Other Exchanges
Address
3480 Peachtree Road NE, Second Floor Suite 103, Atlanta, GA, USA, 30326
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Alzamend Neuro (FRA:9ZT1) Headlines

No Headlines